Pubblicati da julia_l

Palmitoylethanolamide for Nickel Allergy: Plausible, Untested, and Worth Considering

/in /da

Autore: Irene Palenca 1,2,* , Silvia Basili Franzin 3, Giovanni Sarnelli 4 and Giuseppe Esposito 3 1 Neuropharmacology and Behavioral Science Laboratory, Santa Lucia Foundation (IRCCS Fondazione Santa Lucia), 00185 Rome, Italy2 Vice-President, Italian Association of Nickel-Allergic Patients (ASIPAN), 00185 Rome, Italy3 Department of Physiology and Pharmacology “V. Erspamer”, Sapienza University of Rome, Piazzale Aldo […]

Effects of oleoylethanolamide supplementation on inflammatory biomarkers, oxidative stress and antioxidant parameters of obese patients with NAFLD on a calorie-restricted diet: A randomized controlled trial

/in /da

Rivista: Frontiers in Pharmacology Autori: Helda Tutunchi 1 , Farideh Zolrahim 1 , Mahlagha Nikbaf-Shandiz 2, Fatemeh Naeini 3 ,4 , Alireza Ostadrahimi 5 , Sina Naghshi 2 , Reza Salek 1 and Farzad Najafipour 1Endocrine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran, 2 Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran, […]

Biotecnologie Mediche Avanzate al Montalcini Gliobal Biotech Forum

/in /da

Il settore delle Biotecnologie avanzate in campo medico ha registrato negli ultimi anni una rapida espansione con iniziative di “RICERCA E SVILUPPO” che hanno destato l’interesse degli scienziati di tutto il mondo e attenzione attrattiva dei vari fondi di venture capital e di private equity che operano nei settori della ricerca avanzata e nelle biotecnologie […]

Oleoylethanolamide-producing Lactobacillus paracasei F19 improves metabolic and behavioral disorders by restoring intestinal permeability and microbiota-gut-brain axis in high-fat diet-induced obese male mice

/in /da

Rivista: Elsevier Autori: Luisa Seguella a, Chiara Corpetti a, Jie Lu c, Marcella Pesce b, Silvia Basili Franzin a, Irene Palenca a, Aurora Zilli a, Martina Vincenzi a, Daniele Caprioli a, Andreu Paytuví-Gallart d, Walter Sanseverino d, Sara Rurgo b, Giovanni Sarnelli b,* , Giuseppe Esposito a a Department of Physiology and Pharmacology “V. Erspamer”, […]

The gut microbiome and cancer response to immune checkpoint inhibitors

/in /da

Rivista: The Journal of Clinical Investigation Autori: Francesca S. Gazzaniga1 and Dennis L. Kasper2 1 Department of Pathology and Krantz Family Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA. 2 Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, Massachusetts, USA.